BHC
Bausch Health Companies Inc (BHC)
Healthcare • NYSE • $5.75+0.35%
- Symbol
- BHC
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $5.75
- Daily Change
- +0.35%
- Market Cap
- $2.15B
- Trailing P/E
- N/A
- Forward P/E
- 1.42
- 52W High
- $8.69
- 52W Low
- $4.41
- Analyst Target
- $7.57
- Dividend Yield
- N/A
- Beta
- 0.42
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health C…
Company websiteResearch BHC on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.